IART241115C20000
- 1.40
- +0.04+2.94%
Integra Lifesciences Newsroom
Trauma Fixation Device Research Report and Company Analysis 2024-2032 Featuring Zimmer Biomet, Orthofix Medical, B. Braun Meslungen, Stryker, Medtronic, Smith & Nephew, Integra LifeSciences, & Otto - ResearchAndMarkets.com
Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $21
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024
Truist Raises Price Target on Integra LifeSciences Holdings to $26 From $21, Keeps Hold Rating
Daiwa Heavy Report: Will brain-computer interface be the next major medical technology opportunity?
It is stated by DaMo that BCI technology may become an important breakthrough in future medical technology, providing new treatment options for nearly 10 million BCI candidates (patients with neurological diseases), and bringing about a $400 billion market opportunity.
Express News | Honda will recall about 1.7 million autos in the USA.
B of A Securities Maintains Underperform on Integra Lifesciences, Lowers Price Target to $18
BTIG Upgrades Integra Lifesciences(IART.US) to Hold Rating, Maintains Target Price $20
Integra Lifesciences Sell Rating: Overly Ambitious Targets Amid Persistent Operational Challenges
Integra LifeSciences Holdings (NASDAQ:IART) Has A Somewhat Strained Balance Sheet
Unveiling 10 Analyst Insights On Integra Lifesciences
Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Cuts Target Price to $16
Express News | Integra Lifesciences Holdings Corp : Citigroup Cuts Target Price to $16 From $20
Amniotic Membrane Market Research Report 2024-2032 Featuring Stryke, Smith & Nephew, Integra LifeSciences, MiMedx, Organogenesis Net, Wright Medical, Applied Biologics, FzioMed, Katena, Tissue-Tech
Catalyst Watch: Spotlight on Micron, Southwest Airlines, and FOMC Speakers
Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm
Neurology Devices Market Review and Forecast 2020-2030 Featuring Abbott Labs, Zimmer Biomet, Medtronic, Stryker, Integra Lifesciences
Should We Be Cautious About Integra LifeSciences Holdings Corporation's (NASDAQ:IART) ROE Of 1.5%?
Integra LifeSciences Holdings (NASDAQ:IART) Stock Falls 9.0% in Past Week as Three-year Earnings and Shareholder Returns Continue Downward Trend
Wells Fargo Downgrades Integra Lifesciences(IART.US) to Hold Rating, Cuts Target Price to $25
Wells Fargo analyst Vik Chopra downgrades $Integra Lifesciences(IART.US)$ to a hold rating, and adjusts the target price from $45 to $25.According to TipRanks data, the analyst has a success rate of 1